Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 222,884,459 papers from all fields of science
Search
Sign In
Create Free Account
NSC-141540
Known as:
NSC 141540
, NSC141540
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Etoposide
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
Schedule dependency of the antileukemic activity of the podophyllotoxin-derivative VP 16-213 (NSC-141540) in L1210 leukemia.
P. Dombernowsky
,
N. Nissen
Acta pathologica et microbiologica Scandinavica…
2009
Corpus ID: 28099923
The schedule dependency of the antileukemic activity and toxicity of the podophyllotoxin derivative VP 16–213 (NSC-141540) was…
Expand
2004
2004
The role of VP16-213 (Etoposide; NSC-141540) in gestational choriocarcinoma
E. Newlands
,
K. Bagshawe
Cancer Chemotherapy and Pharmacology
2004
Corpus ID: 23026623
SummarySince 1976 we have used VP16-213 (Etoposide; NSC-141540) in several groups of patients with gestational choriocarcinoma…
Expand
Highly Cited
1980
Highly Cited
1980
Anti-tumour activity of the epipodophyllin derivative VP16-213 (etoposide: NSC-141540) in gestational choriocarcinoma.
E. Newlands
,
K. D. Bagshawe
European Journal of Cancer
1980
Corpus ID: 29750872
1975
1975
4'-demethylepipodophyllotoxin 9-(4,6-o-2-thenylidene-beta-D-glucopyranoside) (NSC-122819; VM-26) and 4'-demethylepipodophyllotoxin 9-(4.6-0-ethylidene-beta-D-glucopyranoside) (NSC-141540; VP-16-213…
G. Rivera
,
T. Avery
,
C. Pratt
Cancer chemotherapy reports
1975
Corpus ID: 11888805
We evaluated the responses of 39 children with cancer who, after failure to respond to conventional chemotherapeutic agents…
Expand
1975
1975
Clinical study of the new podophyllotoxin derivative, 4'-demethylepipodophyllotoxin 9-(4,6-o-ethylidene- beta-D-glucopyranoside) (NSC-141540; VP-16-213), in solid tumors.
W. Felix
,
H. Senn
Cancer chemotherapy reports
1975
Corpus ID: 9978553
The new semisynthetic epipodophyllotoxin, 4'-demethylepipodophyllotoxin 9-(4,6-o-ethylidene- beta-D-glucopyranoside) (NSC-141540…
Expand
1974
1974
Phase I clinical trial of weekly administration of 4'-demethylepipodophyllotoxin 9-(4,6-O-ethylidene-beta-D-glucopyranoside) (NSC-141540; VP-16-213).
P. Creaven
,
S. Newman
,
O. Selawry
,
M. Cohen
,
A. Primack
Cancer chemotherapy reports
1974
Corpus ID: 21785135
1972
1972
Phase I clinical trial of a new antitumor agent, 4'-demethylepipodophyllotoxin 9-(4,6-O-ethylidene- -D-glucopyranoside) (NSC-141540; VP-16-213).
N. Nissen
,
V. Larsen
,
H. Pedersen
,
K. Thomsen
Cancer chemotherapy reports
1972
Corpus ID: 2949580
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE